HEADER CHAPERONE 08-NOV-05 2EXL TITLE GRP94 N-TERMINAL DOMAIN BOUND TO GELDANAMYCIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOPLASMIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 69-337; COMPND 5 SYNONYM: 94 KDA GLUCOSE-REGULATED PROTEIN, GRP94; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANIS LUPUS FAMILIARIS; SOURCE 3 ORGANISM_COMMON: DOG; SOURCE 4 ORGANISM_TAXID: 9615; SOURCE 5 STRAIN: FAMILIARIS; SOURCE 6 GENE: TRA1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PGEX-NB-GRP94 KEYWDS GRP94, GP96, HSP90, BERGERAT FOLD, CHAPERONE, ENDOPLASMIC RETICULUM, KEYWDS 2 GELDANAMYCIN, 17-AAG EXPDTA X-RAY DIFFRACTION AUTHOR P.N.REARDON,R.M.IMMORMINO,D.T.GEWIRTH REVDAT 6 23-AUG-23 2EXL 1 REMARK SEQADV REVDAT 5 02-AUG-17 2EXL 1 SOURCE REVDAT 4 29-FEB-12 2EXL 1 HET HETATM VERSN REVDAT 3 24-NOV-10 2EXL 1 JRNL REVDAT 2 24-FEB-09 2EXL 1 VERSN REVDAT 1 24-OCT-06 2EXL 0 JRNL AUTH R.M.IMMORMINO,L.E.METZGER,P.N.REARDON,D.E.DOLLINS,B.S.BLAGG, JRNL AUTH 2 D.T.GEWIRTH JRNL TITL DIFFERENT POSES FOR LIGAND AND CHAPERONE IN INHIBITOR-BOUND JRNL TITL 2 HSP90 AND GRP94: IMPLICATIONS FOR PARALOG-SPECIFIC DRUG JRNL TITL 3 DESIGN. JRNL REF J.MOL.BIOL. V. 388 1033 2009 JRNL REFN ISSN 0022-2836 JRNL PMID 19361515 JRNL DOI 10.1016/J.JMB.2009.03.071 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2205467.350 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 22516 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2252 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.43 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1877 REMARK 3 BIN R VALUE (WORKING SET) : 0.3490 REMARK 3 BIN FREE R VALUE : 0.3840 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 204 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.027 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3249 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 148 REMARK 3 SOLVENT ATOMS : 282 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 2.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.41000 REMARK 3 B22 (A**2) : 1.18000 REMARK 3 B33 (A**2) : 3.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.43 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.49 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 2.150 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.620 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.750 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.930 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.920 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 51.27 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM CNS_TOPPAR REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM CNS_TOPPAR REMARK 3 PARAMETER FILE 3 : PG4_XPLOR_PARAM.PARAM HIC-UP REMARK 3 PARAMETER FILE 4 : 1PE_XPLOR_PARAM.PARAM HIC-UP REMARK 3 PARAMETER FILE 5 : GMYDUN2.PARAM DUNDEE PRODRG REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : PG4_XPLOR_TOP.TOP REMARK 3 TOPOLOGY FILE 4 : 1PE_XPLOR_TOP.TOP REMARK 3 TOPOLOGY FILE 5 : GMYDUN2.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2EXL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 42 REMARK 42 MOLPROBITY STRUCTURE VALIDATION REMARK 42 PROGRAMS : MOLPROBITY (KING, REDUCE, AND PROBE) REMARK 42 AUTHORS : I.W.DAVIS,J.M.WORD REMARK 42 URL : HTTP://KINEMAGE.BIOCHEM.DUKE.EDU/MOLPROBITY/ REMARK 42 AUTHORS : J.S.RICHARDSON,W.B.ARENDALL,D.C.RICHARDSON REMARK 42 REFERENCE : NEW TOOLS AND DATA FOR IMPROVING REMARK 42 : STRUCTURES, USING ALL-ATOM CONTACTS REMARK 42 : METHODS IN ENZYMOLOGY. 2003;374:385-412. REMARK 42 MOLPROBITY OUTPUT SCORES: REMARK 42 ALL-ATOM CLASHSCORE : 12.00 (9.77 B<40) REMARK 42 BAD ROTAMERS : 0.8% 3/363 (TARGET 0-1%) REMARK 42 RAMACHANDRAN OUTLIERS : 0.3% 1/398 (TARGET 0.2%) REMARK 42 RAMACHANDRAN FAVORED : 94.7% 377/398 (TARGET 98.0%) REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1000035217. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 102 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : COPPER KALPHA REMARK 200 OPTICS : YALE MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22646 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.0600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 46.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.28500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.550 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1YT1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 34% PEG400, 60 MM MGCL2, TRIS PH 7.6, REMARK 280 GELDANAMYCIN DELIVERED AS 5UL TO 50UL OF PROTEIN STOCK REMARK 280 GELDANAMYCIN IS 50MM, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.91000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.81500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.18000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.81500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.91000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.18000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ONE PROTOMER IN THE ASYMMETRIC UNIT COMPRISES THE ASSUMED REMARK 300 BIOLOGICAL MOLECULE REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 65 REMARK 465 SER A 66 REMARK 465 HIS A 67 REMARK 465 MET A 68 REMARK 465 LEU A 69 REMARK 465 ARG A 70 REMARK 465 GLU A 71 REMARK 465 LYS A 168 REMARK 465 SER A 169 REMARK 465 GLY A 170 REMARK 465 THR A 171 REMARK 465 SER A 172 REMARK 465 GLU A 173 REMARK 465 PHE A 174 REMARK 465 LEU A 175 REMARK 465 ASN A 176 REMARK 465 LYS A 177 REMARK 465 MET A 178 REMARK 465 THR A 179 REMARK 465 GLU A 180 REMARK 465 ALA A 181 REMARK 465 GLN A 182 REMARK 465 GLU A 183 REMARK 465 ASP A 184 REMARK 465 GLY A 185 REMARK 465 GLN A 186 REMARK 465 GLY A 324 REMARK 465 GLY A 325 REMARK 465 GLY A 326 REMARK 465 GLY A 327 REMARK 465 GLY B 65 REMARK 465 SER B 66 REMARK 465 HIS B 67 REMARK 465 MET B 68 REMARK 465 LEU B 69 REMARK 465 ARG B 70 REMARK 465 GLU B 71 REMARK 465 LYS B 72 REMARK 465 ALA B 167 REMARK 465 LYS B 168 REMARK 465 SER B 169 REMARK 465 GLY B 170 REMARK 465 THR B 171 REMARK 465 SER B 172 REMARK 465 GLU B 173 REMARK 465 PHE B 174 REMARK 465 LEU B 175 REMARK 465 ASN B 176 REMARK 465 LYS B 177 REMARK 465 MET B 178 REMARK 465 THR B 179 REMARK 465 GLU B 180 REMARK 465 ALA B 181 REMARK 465 GLN B 182 REMARK 465 GLU B 183 REMARK 465 ASP B 184 REMARK 465 GLY B 185 REMARK 465 GLN B 186 REMARK 465 GLY B 324 REMARK 465 GLY B 325 REMARK 465 GLY B 326 REMARK 465 GLY B 327 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 72 CG CD CE NZ REMARK 470 PHE A 195 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 140 CG CD CE NZ REMARK 470 GLU B 157 CG CD OE1 OE2 REMARK 470 ILE B 166 CG1 CG2 CD1 REMARK 470 PHE B 195 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 94 -5.65 -59.45 REMARK 500 ASN A 96 55.76 -160.01 REMARK 500 GLU A 98 -7.01 -57.94 REMARK 500 LEU A 126 62.32 -108.99 REMARK 500 ASN A 129 95.09 -176.91 REMARK 500 SER A 227 -4.66 92.29 REMARK 500 GLU A 229 177.68 170.50 REMARK 500 LEU B 126 35.34 -91.03 REMARK 500 ASN B 129 112.77 -173.68 REMARK 500 SER B 227 -18.83 88.84 REMARK 500 GLU B 229 -171.32 172.64 REMARK 500 ARG B 243 143.35 -176.64 REMARK 500 TRP B 282 97.87 -53.12 REMARK 500 ASP B 332 153.86 178.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ONLY FRAGMENTS OF PEG400 WERE IDENTIFIED AND IN REMARK 600 MANY CASES SEVERAL ATOMS WERE MISSING DUE TO LACK OF REMARK 600 ELECTRON DENSITY. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDM A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDM B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 508 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1PE A 409 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QY5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 REMARK 900 IN COMPLEX WITH THE SPECIFIC LIGAND NECA REMARK 900 RELATED ID: 1U20 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE N-DOMAIN OF GRP94 LACKING THE CHARGED REMARK 900 DOMAIN IN COMPLEX WITH NECA REMARK 900 RELATED ID: 2ESA RELATED DB: PDB REMARK 900 GRP94 N-TERMINAL DOMAIN BOUND TO GELDANAMYCIN: EFFECTS OF MUTANTS REMARK 900 168-169 KS-AA REMARK 900 RELATED ID: 1YT1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94, THE ER HSP90: REMARK 900 BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE, GRP94N(DELTA)41 REMARK 900 APO CRYSTAL REMARK 900 RELATED ID: 1TC6 RELATED DB: PDB REMARK 900 LIGAND INDUCED CONFORMATIONAL SHIFT IN THE N-TERMINAL DOMAIN OF REMARK 900 GRP94, OPEN CONFORMATION ADP-COMPLEX REMARK 900 RELATED ID: 1TBW RELATED DB: PDB REMARK 900 LIGAND INDUCED CONFORMATIONAL SHIFT IN THE N-TERMINAL DOMAIN OF REMARK 900 GRP94, OPEN CONFORMATION REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE DATABASE RESIDUES 287-327 WERE DELETED REMARK 999 AND REPLACED BY 4 GLYCINES. DBREF 2EXL A 69 286 UNP P41148 ENPL_CANFA 69 286 DBREF 2EXL A 328 337 UNP P41148 ENPL_CANFA 328 337 DBREF 2EXL B 69 286 UNP P41148 ENPL_CANFA 69 286 DBREF 2EXL B 328 337 UNP P41148 ENPL_CANFA 328 337 SEQADV 2EXL GLY A 65 UNP P41148 CLONING ARTIFACT SEQADV 2EXL SER A 66 UNP P41148 CLONING ARTIFACT SEQADV 2EXL HIS A 67 UNP P41148 CLONING ARTIFACT SEQADV 2EXL MET A 68 UNP P41148 CLONING ARTIFACT SEQADV 2EXL GLY A 324 UNP P41148 SEE REMARK 999 SEQADV 2EXL GLY A 325 UNP P41148 SEE REMARK 999 SEQADV 2EXL GLY A 326 UNP P41148 SEE REMARK 999 SEQADV 2EXL GLY A 327 UNP P41148 SEE REMARK 999 SEQADV 2EXL GLY B 65 UNP P41148 CLONING ARTIFACT SEQADV 2EXL SER B 66 UNP P41148 CLONING ARTIFACT SEQADV 2EXL HIS B 67 UNP P41148 CLONING ARTIFACT SEQADV 2EXL MET B 68 UNP P41148 CLONING ARTIFACT SEQADV 2EXL GLY B 324 UNP P41148 SEE REMARK 999 SEQADV 2EXL GLY B 325 UNP P41148 SEE REMARK 999 SEQADV 2EXL GLY B 326 UNP P41148 SEE REMARK 999 SEQADV 2EXL GLY B 327 UNP P41148 SEE REMARK 999 SEQRES 1 A 236 GLY SER HIS MET LEU ARG GLU LYS SER GLU LYS PHE ALA SEQRES 2 A 236 PHE GLN ALA GLU VAL ASN ARG MET MET LYS LEU ILE ILE SEQRES 3 A 236 ASN SER LEU TYR LYS ASN LYS GLU ILE PHE LEU ARG GLU SEQRES 4 A 236 LEU ILE SER ASN ALA SER ASP ALA LEU ASP LYS ILE ARG SEQRES 5 A 236 LEU ILE SER LEU THR ASP GLU ASN ALA LEU ALA GLY ASN SEQRES 6 A 236 GLU GLU LEU THR VAL LYS ILE LYS CYS ASP LYS GLU LYS SEQRES 7 A 236 ASN LEU LEU HIS VAL THR ASP THR GLY VAL GLY MET THR SEQRES 8 A 236 ARG GLU GLU LEU VAL LYS ASN LEU GLY THR ILE ALA LYS SEQRES 9 A 236 SER GLY THR SER GLU PHE LEU ASN LYS MET THR GLU ALA SEQRES 10 A 236 GLN GLU ASP GLY GLN SER THR SER GLU LEU ILE GLY GLN SEQRES 11 A 236 PHE GLY VAL GLY PHE TYR SER ALA PHE LEU VAL ALA ASP SEQRES 12 A 236 LYS VAL ILE VAL THR SER LYS HIS ASN ASN ASP THR GLN SEQRES 13 A 236 HIS ILE TRP GLU SER ASP SER ASN GLU PHE SER VAL ILE SEQRES 14 A 236 ALA ASP PRO ARG GLY ASN THR LEU GLY ARG GLY THR THR SEQRES 15 A 236 ILE THR LEU VAL LEU LYS GLU GLU ALA SER ASP TYR LEU SEQRES 16 A 236 GLU LEU ASP THR ILE LYS ASN LEU VAL LYS LYS TYR SER SEQRES 17 A 236 GLN PHE ILE ASN PHE PRO ILE TYR VAL TRP SER SER LYS SEQRES 18 A 236 THR GLY GLY GLY GLY LYS THR VAL TRP ASP TRP GLU LEU SEQRES 19 A 236 MET ASN SEQRES 1 B 236 GLY SER HIS MET LEU ARG GLU LYS SER GLU LYS PHE ALA SEQRES 2 B 236 PHE GLN ALA GLU VAL ASN ARG MET MET LYS LEU ILE ILE SEQRES 3 B 236 ASN SER LEU TYR LYS ASN LYS GLU ILE PHE LEU ARG GLU SEQRES 4 B 236 LEU ILE SER ASN ALA SER ASP ALA LEU ASP LYS ILE ARG SEQRES 5 B 236 LEU ILE SER LEU THR ASP GLU ASN ALA LEU ALA GLY ASN SEQRES 6 B 236 GLU GLU LEU THR VAL LYS ILE LYS CYS ASP LYS GLU LYS SEQRES 7 B 236 ASN LEU LEU HIS VAL THR ASP THR GLY VAL GLY MET THR SEQRES 8 B 236 ARG GLU GLU LEU VAL LYS ASN LEU GLY THR ILE ALA LYS SEQRES 9 B 236 SER GLY THR SER GLU PHE LEU ASN LYS MET THR GLU ALA SEQRES 10 B 236 GLN GLU ASP GLY GLN SER THR SER GLU LEU ILE GLY GLN SEQRES 11 B 236 PHE GLY VAL GLY PHE TYR SER ALA PHE LEU VAL ALA ASP SEQRES 12 B 236 LYS VAL ILE VAL THR SER LYS HIS ASN ASN ASP THR GLN SEQRES 13 B 236 HIS ILE TRP GLU SER ASP SER ASN GLU PHE SER VAL ILE SEQRES 14 B 236 ALA ASP PRO ARG GLY ASN THR LEU GLY ARG GLY THR THR SEQRES 15 B 236 ILE THR LEU VAL LEU LYS GLU GLU ALA SER ASP TYR LEU SEQRES 16 B 236 GLU LEU ASP THR ILE LYS ASN LEU VAL LYS LYS TYR SER SEQRES 17 B 236 GLN PHE ILE ASN PHE PRO ILE TYR VAL TRP SER SER LYS SEQRES 18 B 236 THR GLY GLY GLY GLY LYS THR VAL TRP ASP TRP GLU LEU SEQRES 19 B 236 MET ASN HET GDM A 301 40 HET PG4 A 501 13 HET PG4 A 502 13 HET 1PE A 409 16 HET GDM B 302 40 HET PG4 B 508 13 HET PG4 B 406 13 HETNAM GDM GELDANAMYCIN HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM 1PE PENTAETHYLENE GLYCOL HETSYN 1PE PEG400 FORMUL 3 GDM 2(C29 H40 N2 O9) FORMUL 4 PG4 4(C8 H18 O5) FORMUL 6 1PE C10 H22 O6 FORMUL 10 HOH *282(H2 O) HELIX 1 1 GLN A 79 TYR A 94 1 16 HELIX 2 2 GLU A 98 ASP A 122 1 25 HELIX 3 3 THR A 155 THR A 165 1 11 HELIX 4 4 THR A 188 GLY A 196 1 9 HELIX 5 5 VAL A 197 LEU A 204 5 8 HELIX 6 6 GLU A 253 LEU A 259 5 7 HELIX 7 7 GLU A 260 GLN A 273 1 14 HELIX 8 8 GLN B 79 LEU B 93 1 15 HELIX 9 9 GLU B 98 ASP B 122 1 25 HELIX 10 10 THR B 155 THR B 165 1 11 HELIX 11 11 THR B 188 GLU B 190 5 3 HELIX 12 12 LEU B 191 GLY B 196 1 6 HELIX 13 13 VAL B 197 LEU B 204 5 8 HELIX 14 14 GLU B 253 LEU B 259 5 7 HELIX 15 15 GLU B 260 GLN B 273 1 14 SHEET 1 A 9 LYS A 75 PHE A 76 0 SHEET 2 A 9 PHE A 230 ALA A 234 -1 O PHE A 230 N PHE A 76 SHEET 3 A 9 HIS A 221 SER A 225 -1 N ILE A 222 O ILE A 233 SHEET 4 A 9 ALA A 206 LYS A 214 -1 N VAL A 211 O TRP A 223 SHEET 5 A 9 GLY A 244 LEU A 251 -1 O THR A 248 N ILE A 210 SHEET 6 A 9 LEU A 144 ASP A 149 -1 N VAL A 147 O ILE A 247 SHEET 7 A 9 VAL A 134 ASP A 139 -1 N LYS A 135 O THR A 148 SHEET 8 A 9 ILE A 279 LYS A 285 1 O TRP A 282 N ILE A 136 SHEET 9 A 9 VAL A 330 LEU A 335 -1 O ASP A 332 N SER A 283 SHEET 1 B 8 LYS B 75 PHE B 76 0 SHEET 2 B 8 PHE B 230 ALA B 234 -1 O PHE B 230 N PHE B 76 SHEET 3 B 8 HIS B 221 SER B 225 -1 N ILE B 222 O ILE B 233 SHEET 4 B 8 ALA B 206 LYS B 214 -1 N VAL B 211 O TRP B 223 SHEET 5 B 8 GLY B 244 LEU B 251 -1 O THR B 246 N THR B 212 SHEET 6 B 8 LEU B 144 ASP B 149 -1 N LEU B 145 O LEU B 249 SHEET 7 B 8 VAL B 134 ASP B 139 -1 N LYS B 135 O THR B 148 SHEET 8 B 8 ILE B 279 VAL B 281 1 O TYR B 280 N ILE B 136 SHEET 1 C 2 SER B 283 LYS B 285 0 SHEET 2 C 2 VAL B 330 ASP B 332 -1 O VAL B 330 N LYS B 285 SITE 1 AC1 17 ASN A 107 ALA A 108 ASP A 110 LYS A 114 SITE 2 AC1 17 ASP A 149 MET A 154 ASN A 162 LEU A 163 SITE 3 AC1 17 GLY A 196 VAL A 197 GLY A 198 PHE A 199 SITE 4 AC1 17 THR A 245 HOH A 504 HOH A 505 HOH A 558 SITE 5 AC1 17 HOH A 592 SITE 1 AC2 17 ASN B 107 ALA B 108 ASP B 110 ALA B 111 SITE 2 AC2 17 LYS B 114 ASP B 149 MET B 154 ASN B 162 SITE 3 AC2 17 LEU B 163 GLY B 196 VAL B 197 GLY B 198 SITE 4 AC2 17 PHE B 199 HOH B 512 HOH B 513 HOH B 526 SITE 5 AC2 17 HOH B 541 SITE 1 AC3 10 THR A 212 ARG A 237 THR A 240 THR A 248 SITE 2 AC3 10 PG4 A 502 HOH A 507 HOH A 518 HOH A 574 SITE 3 AC3 10 HOH A 575 LEU B 117 SITE 1 AC4 7 LYS A 137 HIS A 146 THR A 148 TRP A 282 SITE 2 AC4 7 PG4 A 501 HOH A 503 HOH A 601 SITE 1 AC5 10 LEU A 117 HOH A 598 LYS B 142 THR B 212 SITE 2 AC5 10 ARG B 237 THR B 248 PG4 B 406 HOH B 539 SITE 3 AC5 10 HOH B 570 HOH B 601 SITE 1 AC6 5 LYS B 137 HIS B 146 TRP B 282 PG4 B 508 SITE 2 AC6 5 HOH B 599 SITE 1 AC7 8 ASN A 83 LYS A 87 SER A 227 HOH A 602 SITE 2 AC7 8 ASN B 83 LYS B 87 ILE B 90 HOH B 523 CRYST1 65.820 84.360 95.630 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015193 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011854 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010457 0.00000